Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...
News Medical on MSN10h
Gene Therapy Discovery Enables Use for Muscular Dystrophies and Large-Gene DiseasesA new technology that delivers two halves of a gene separately could enable gene therapy treatments of muscular dystrophies.
New immunology data for INO-3107 supporting proposed mechanism of action presented at several recent conferences Data showed ability of INO-3107 to induce an antigen-specific cytotoxic T cell response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback